Overview
What It Is Medtronic BrainSense technology adds sensing and adaptive capabilities to compatible deep-brain stimulation systems. The device can record brain signals and adjust stimulation based on those signals rather than delivering only continuous open-loop stimulation.
How It Works Sensing local field potentials allows the system to respond to the brain’s current state (for example, markers associated with Parkinsonian symptoms). Adaptive adjustment aims for better symptom control with fewer side effects and may support more physiological network dynamics over time.
Conditions - Primary context: Parkinson’s disease and other approved DBS indications where sensing-capable hardware is available. - Note: Programming is managed in clinic. Coverage generally follows standard DBS pathways when criteria are met.
How it is administered
Used with compatible implanted DBS systems. Sensing and adaptive features are programmed and managed in clinic; the device adjusts stimulation based on sensed brain signals.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 1 condition record. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Emotion & Behavior
- anxiety
- apathy
- Depression
- mood changes
Motor Control
- balance and gait problems
- rigidity/stiffness
- slowed movement (bradykinesia)
- Tremor
Practical information
Insurance coverage
Generally follows standard DBS coverage when indication and hardware criteria are met.
Cost information
High (part of DBS system costs); typically covered when medically necessary.
Results and outcomes described in the source record
Symptom control assessed over weeks to months after programming; adaptive benefits develop with ongoing use.
Side effects and risks
Surgical and stimulation-related risks similar to conventional DBS (speech, mood, balance changes possible).
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Moderate to Strong (within DBS indications) What the research shows: Sensing-enabled adaptive DBS aims to improve symptom control by responding to real-time neural signals. Key takeaway: An advanced DBS feature set for eligible patients with compatible hardware.
Research detail
Overview Medtronic BrainSense enables sensing and adaptive stimulation on compatible DBS systems.
Evidence Base and Published Work • Studies of adaptive/closed-loop DBS in Parkinson’s support safety and performance benefits of sensing-based adjustment. • Related reviews of adaptive DBS technologies document ongoing clinical adoption.
Outcomes Outcomes most frequently described include improved symptom stability and potential side-effect reduction compared with continuous open-loop stimulation in selected patients.
Questions to ask a provider
1. Does BrainSense adaptive DBS technology apply to my condition and existing or planned hardware? 2. How does sensing and automatic adjustment differ from conventional continuous DBS? 3. What benefits in symptom control or side-effect reduction have been observed? 4. Will my system support BrainSense, or is new hardware required? 5. Is BrainSense programming covered in the same way as standard DBS management?
Website and contact information
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database